Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Edus H Warren

Showing results (41-50 of 87) with videos related to

Pageof 9
Sort By:
Blood|March 9, 2017
Validation of single nucleotide polymorphisms in invasive aspergillosis following hematopoietic cell transplantationCynthia E Fisher, Tobias M Hohl, Wenhong Fan, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|March 29, 2011
Activation and expansion of CD8(+) T effector cells in patients with chronic graft-versus-host diseaseBryan M Grogan, Laura Tabellini, Barry Storer, et al.
Blood|June 3, 2011
Influence of immunosuppressive treatment on risk of recurrent malignancy after allogeneic hematopoietic cell transplantationYoshihiro Inamoto, Mary E D Flowers, Stephanie J Lee, et al.
British Journal of Haematology|November 18, 2003
Disparity for a newly identified minor histocompatibility antigen, HA-8, correlates with acute graft-versus-host disease after haematopoietic stem cell transplantation from an HLA-identical siblingYoshiki Akatsuka, Edus H Warren, Ted A Gooley, et al.
Clinical Lymphoma, Myeloma & Leukemia|May 8, 2025
Ibrutinib and Venetoclax in Relapsed and Refractory Follicular LymphomaChaitra Ujjani, Hongkun Wang, Catherine Broome, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 15, 2011
A phase I/II study of chemotherapy followed by donor lymphocyte infusion plus interleukin-2 for relapsed acute leukemia after allogeneic hematopoietic cell transplantationYoshihiro Inamoto, Alexander Fefer, Brenda M Sandmaier, et al.
Journal of Virology|February 6, 2015
Dynamics of the cytotoxic T cell response to a model of acute viral infectionWilliam S DeWitt, Ryan O Emerson, Paul Lindau, et al.
Nature Communications|January 11, 2022
CD4 and CD8 co-receptors modulate functional avidity of CD1b-restricted T cellsCharlotte A James, Yuexin Xu, Melissa S Aguilar, et al.
Blood|March 14, 2015
Allogeneic HY antibodies detected 3 months after female-to-male HCT predict chronic GVHD and nonrelapse mortality in humansHideki Nakasone, Lu Tian, Bita Sahaf, et al.
American Journal of Hematology|June 17, 2026
Outcomes From the Multicenter ACCRU-LY-1804/CARiBOU TRIAL (Cytarabine, Acalabrutinib and Rituximab Integrated With Bortezomib-Based Outpatient Therapy) in 1st Line Mantle Cell LymphomaStephen D Smith, Suchitra Sundaram, Sharmila Giri, et al.
Pageof 9

Showing results (41-50 of 87) with videos related to

Sort By:
Pageof 9
Blood|March 9, 2017
Validation of single nucleotide polymorphisms in invasive aspergillosis following hematopoietic cell transplantationCynthia E Fisher, Tobias M Hohl, Wenhong Fan, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|March 29, 2011
Activation and expansion of CD8(+) T effector cells in patients with chronic graft-versus-host diseaseBryan M Grogan, Laura Tabellini, Barry Storer, et al.
Blood|June 3, 2011
Influence of immunosuppressive treatment on risk of recurrent malignancy after allogeneic hematopoietic cell transplantationYoshihiro Inamoto, Mary E D Flowers, Stephanie J Lee, et al.
British Journal of Haematology|November 18, 2003
Disparity for a newly identified minor histocompatibility antigen, HA-8, correlates with acute graft-versus-host disease after haematopoietic stem cell transplantation from an HLA-identical siblingYoshiki Akatsuka, Edus H Warren, Ted A Gooley, et al.
Clinical Lymphoma, Myeloma & Leukemia|May 8, 2025
Ibrutinib and Venetoclax in Relapsed and Refractory Follicular LymphomaChaitra Ujjani, Hongkun Wang, Catherine Broome, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 15, 2011
A phase I/II study of chemotherapy followed by donor lymphocyte infusion plus interleukin-2 for relapsed acute leukemia after allogeneic hematopoietic cell transplantationYoshihiro Inamoto, Alexander Fefer, Brenda M Sandmaier, et al.
Journal of Virology|February 6, 2015
Dynamics of the cytotoxic T cell response to a model of acute viral infectionWilliam S DeWitt, Ryan O Emerson, Paul Lindau, et al.
Nature Communications|January 11, 2022
CD4 and CD8 co-receptors modulate functional avidity of CD1b-restricted T cellsCharlotte A James, Yuexin Xu, Melissa S Aguilar, et al.
Blood|March 14, 2015
Allogeneic HY antibodies detected 3 months after female-to-male HCT predict chronic GVHD and nonrelapse mortality in humansHideki Nakasone, Lu Tian, Bita Sahaf, et al.
American Journal of Hematology|June 17, 2026
Outcomes From the Multicenter ACCRU-LY-1804/CARiBOU TRIAL (Cytarabine, Acalabrutinib and Rituximab Integrated With Bortezomib-Based Outpatient Therapy) in 1st Line Mantle Cell LymphomaStephen D Smith, Suchitra Sundaram, Sharmila Giri, et al.
Pageof 9